Changes in body weight reflect disease progression in pleuroparenchymal fibroelastosis
Author:
Funder
Japan Society for the Promotion of Science
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference16 articles.
1. Progesterone therapy for the treatment of non-cancer cachexia: a systematic review;Taylor;BMJ Support Palliat Care,2016
2. Idiopathic pulmonary upper lobe fibrosis;Amitani;Kokyu,1992
3. The clinical significance of body weight loss in idiopathic pulmonary fibrosis patients;Nakatsuka;Respiration,2018
4. Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: a proposal;Watanabe;Respir Investig,2019
5. Limited efficacy of nintedanib for idiopathic pleuroparenchymal fibroelastosis;Kinoshita;Respir Investig,2022
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Body weight loss is a simple and useful indicator of prognosis and predictive tolerability in the first year of nintedanib therapy in patients with interstitial lung disease;Respiratory Investigation;2024-07
2. Proposed Clinical Algorithm for Pleuroparenchymal Fibroelastosis (PPFE);Journal of Clinical Medicine;2024-06-24
3. Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK;ERJ Open Research;2024-01
4. PROGNOSTIC SIGNIFICANCE OF BODY MASS INDEX AND WEIGHT LOSS IN PATIENTS WITH IDIOPATHIC PLEUROPARENCHYMAL FIBROELASTOSIS;SARCOIDOSIS VASC DIF;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3